Hepatitis C
Caffeine and Liver Disease in People with Hepatitis C
- Details
- Category: Fibrosis & Cirrhosis
- Published on Tuesday, 31 May 2011 14:04
Regularly consuming larger amounts of caffeine has a significant beneficial effect on liver inflammation, but not fibrosis, according to biopsy results from people with chronic hepatitis C. 
Telaprevir (Incivek) Approved for Hepatitis C
- Details
- Category: Approved HCV Drugs
- Published on Tuesday, 24 May 2011 14:19
Screen for HCV Based on Age, Not Risk Factors
- Details
- Category: HCV Testing & Diagnosis
- Published on Friday, 13 May 2011 15:26
FDA OKs New Abbott HCV Test
- Details
- Category: HCV Testing & Diagnosis
- Published on Tuesday, 24 May 2011 13:56
Abbott last week announced that the FDA approved a new PCR blood test for hepatitis C virus (HCV) with a 12 IU/mL limit of detection and quantification.
Is Hepatitis C Rising among Young People?
- Details
- Category: HCV Epidemiology & Mortality
- Published on Friday, 13 May 2011 15:11
Massachusetts surveillance data showed an increase in hepatitis C among adolescents and young adults during 2002-2009, thought to be largely attributable to injection drug use.
European Committee Recommends Boceprevir (Victrelis)
- Details
- Category: Approved HCV Drugs
- Published on Friday, 20 May 2011 14:35
The European Medicines Agency's Committee for Medicinal Products for Human Use has recommended approval of the HCV protease inhibitor boceprevir (brand name Victrelis) for treatment of chronic hepatitis C.
Prenatal HBV Screening Helps Babies More than Moms
- Details
- Category: Pregnancy & HCV MTCT
- Published on Friday, 13 May 2011 07:59
Routine screening for hepatitis B virus (HBV) during pregnancy enables most infants to be protected against infection, but underserved mothers often do not receive education about or care for their own infection, researchers reported this week at DDW 2011.
Boceprevir (Victrelis) Approved for Hepatitis C
- Details
- Category: Approved HCV Drugs
- Published on Monday, 16 May 2011 17:02
Longer Interferon Treatment Raises Hepatitis C Cure Rate
- Details
- Category: HCV Treatment
- Published on Tuesday, 10 May 2011 15:06
Meta-analysis finds that extending pegylated interferon plus ribavirin to 72 weeks may improve sustained response rates for late-responder genotype 1 hepatitis C patients. 
More Articles...
- EASL Releases New Hepatitis C Clinical Practice Guidelines
- FDA Committee Unanimously Recommends Telaprevir (Incivek)
- Boceprevir for HCV Wins Unanimous FDA Committee Recommendation
- Viral Load, HIV Status, but not IL28B Predict Perinatal HCV Transmission
- BI 201335 for Hepatitis C Moves into Phase 3 Trials
Web Design and Development by